Key result
Female sex is not linked to worse long-term survival after pulmonary endarterectomy for CTEPH.
Why the study?
Whether long-term prognosis differs between men and women following pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension remains unclear.
Does female sex reduce survival in patients undergoing pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension?
Cohort (n=444)
Yes
Does female sex reduce survival in patients undergoing pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension?
Hazard Ratio: 1.36 (95% CI 0.89–2.06)
While women experience higher early mortality after pulmonary endarterectomy for CTEPH, long-term survival does not differ significantly between sexes after adjusting for baseline characteristics.
Sex-specific post-PEA survival in CTEPH remains uncertain; leaves open whether sex should inform risk stratification or follow-up.
Studies have suggested sex-related survival differences in chronic thromboembolic pulmonary hypertension (CTEPH). Whether long-term prognosis differs between men and women following pulmonary endarterectomy for CTEPH remains unclear. We investigated sex-specific survival after pulmonary endarterectomy for CTEPH. We included all patients who underwent pulmonary endarterectomy for CTEPH at two Scandinavian centers and obtained baseline characteristics and vital statuses from patient charts and national health-data registers. Propensity scores and weighting were used to account for baseline differences. Flexible parametric survival models were employed to estimate the association between sex and all-cause mortality and the absolute survival differences. The expected survival in an age-, sex-, and year of surgery matched general population was obtained from the Human Mortality Database, and the relative survival was used to estimate cause-specific mortality. A total of 444 patients were included, comprising 260 (59%) men and 184 (41%) women. Unadjusted 30-day mortality was 4.2% in men versus 9.8% in women (p = 0.020). In weighted analyses, long-term survival did not differ significantly in women compared with men (hazard ratio: 1.36; 95% confidence interval: 0.89-2.06). Relative survival at 15 years conditional on 30-day survival was 94% (79%-107%) in men versus 75% (59%-88%) in women. In patients who underwent pulmonary endarterectomy for CTEPH, early mortality was higher in women compared with men. After adjustment for differences in baseline characteristics, female sex was not associated with long-term survival. However, relative survival analyses suggested that the observed survival in men was close to the expected survival in the matched general population, whereas survival in women deviated notably from the matched general population.
No takes yet. Share an insight, caveat, or question.
Kallonen et al. (2021) conducted a cohort in chronic thromboembolic pulmonary hypertension (CTEPH) (n=444). Female sex vs. Male sex was evaluated on long-term survival (HR 1.36, 95% CI 0.89-2.06). Following pulmonary endarterectomy for CTEPH, female sex was not significantly associated with worse long-term survival compared to male sex (HR 1.36; 95% CI 0.89-2.06).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: